EBRCZ.US EBR Systems Inc.
- Market cap
- USD 70.0M
- P/E
- -
- P/B
- 0.91x
- ROE
- -87.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is EBRCZ.US undervalued?
Graham numberThe Graham number of EBR Systems Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
EBR Systems Inc. fundamental analysis
No fundamental analysis for EBR Systems Inc. yet.
EBR Systems Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About EBR Systems Inc.
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporate…
Full company profileEBR Systems Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
EBR Systems Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1.29M | - | - | - | 0.00 | 0.00 | 1.62M | 9.87M |
| Gross Profit | -5.78M | - | -371K | -641K | -772K | -551K | 490K | 1.03M |
| Operating Income | -25.4M | -20.6K | -22.8K | -24.3M | -34.5M | -35.9M | -47.7M | -64.0M |
| EBITDA | -25.2M | -20.5M | -19.8M | -39.1M | -30.5M | -32.1M | -47.3M | -63.0M |
| Net Income | -24.8M | -25.7K | -39.8M | -33.1M | -35.0M | -20.2M | -48.8M | -67.1M |
| EPS | -0.19 | 0.00 | -0.95 | -0.12 | -0.12 | -0.06 | -0.12 | -0.08 |
| Balance Sheet | ||||||||
| Total Assets | 12.4M | 8.40M | 85.4M | 71.7M | 78.9M | 73.6M | 97.2M | 147M |
| Total Liabilities | 26.2M | 46.0M | 9.53M | 27.7M | 47.8M | 49.2M | 71.6M | 70.3M |
| Shareholders' Equity | -13.8M | -37.7M | 75.9M | 43.9M | 31.1M | 24.4M | 25.6M | 76.9M |
| Cash & Short-term Investments | 7.29M | 5.88M | 78.2M | 63.5M | 72.3M | 60.7M | 53.2M | 85.4M |
| Total Debt | 18.5M | 33.2M | 4.81M | 21.6M | 41.6M | 41.4M | 58.6M | 59.8M |
| Cash Flow | ||||||||
| Operating Cash Flow | -21.1K | -17.5K | -22.1K | -30.4M | -32.7M | -41.2M | -53.2M | -72.9M |
| Capital Expenditure | 242.13 | 265.30 | 912K | 730K | 354K | 273K | 3.68M | 8.30M |
| Free Cash Flow | -21.3K | -17.8K | -934K | -31.1M | -33.1M | -41.5M | -56.9M | -81.2M |
| Ratios | ||||||||
| ROE | - | - | -52.5% | -75.3% | -112.8% | -82.8% | -190.6% | -87.3% |
| ROA | -200.3% | -0.3% | -46.6% | -46.2% | -44.4% | -27.4% | -50.1% | -45.6% |
| Net Profit Margin | -1,917.6% | - | - | - | - | - | -3,015.3% | -680.1% |
| Debt to Equity | - | - | 0.06x | 0.49x | 1.34x | 1.70x | 2.29x | 0.78x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
EBR Systems Inc. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | USD 1.15M | 0.00 | - |
| 2022 | USD 1.01M | 0.00 | - |
| 2021 | USD 5.19M | 0.12 | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 267:250 on Jun 8, 2026.
Who owns EBR Systems Inc.
- Insiders 0.91%
- Institutions 41.20%
- Public & others 57.89%
- Shares outstanding 845M
- Free float 698M
EBR Systems Inc. company profile
- Company name
- EBR Systems Inc.
- Ticker
- EBRCZ.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 135
- Fiscal year end
- December
- Address
- 480 Oakmead Parkway, Sunnyvale, CA, United States, 94085
- Phone
- 408 720 1906
- Website
- ebrsystemsinc.com
About EBR Systems Inc.
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.
EBR Systems Inc. management
10- Mr. Allan Roger Will B.S., M.S.Executive Chairman · born 1955
- Mr. John Graham McCutcheon B.A., M.B.A.President, CEO & Director · born 1961
- Mr. Gary W. Doherty B.S.Chief Financial Officer · born 1966
- Mr. Michael Hendricksen B.S., M.S.Chief Operating Officer · born 1974
- Dr. N. Parker Willis B.S., M.S., Ph.D.Chief Technology Officer · born 1967
- Mr. Andrew Shute B.S.Chief Corporate Development Officer · born 1973
- Ms. Aimee EinsteinChief Human Resources Officer
- Dr. Spencer H. Kubo M.D.Chief Medical Officer · born 1956
- Ms. Pharoah GarmaChief Regulatory Officer
- Dr. Robert C. Canby M.D.Chief Medical Officer